CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Goldman Sachs Adjusts Price Target on Regeneron Pharmaceuticals to $965 From $968, Maintains Buy Rating

Neutral
AI Analysis

Summary

Goldman Sachs adjusted its price target on Regeneron Pharmaceuticals down slightly from $968 to $965 while maintaining a Buy rating.

Importance:2/10
Sentiment:
0.00
price_targetanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on July 20, 2026 12:37 PM

Read Original